Potential Misuse and Abuse of Opioids Has Led to Stringent Government Regulations in Non-Opioid Pain Relief Device Market

Non Opioid Pain Relief Device Market

There has been significant alteration within the lifestyle pattern of people on a global level due to the emergence of work ethics that require long work durations, poor body postures, lead to high level of stress and trauma, further leading to chronic pain disorders. Also, high prevalence of traumatic injuries and road accidents has also led to a surge in chronic pain incidences. According to the analysis by CDC for National Health Interview Survey (NHIS) in 2016, an estimated 20.4% (50.0 million) of U.S. adults suffered from chronic pain and 8.0% of U.S. adults (19.6 million) suffered from high-impact chronic pain, with higher prevalence of both chronic pain and high-impact chronic pain reported among women, older adults.

Read Full report of Non-Opioid Pain Relief Device Market

Impact of Chronic Pain Disorders on the Quality of Life

According to the World Health Organization (WHO) report of 2013, the top four causes of chronic pain disorders are migraine, lower back pain, neck pain, and musculoskeletal disorders. Chronic pain has several detrimental effects on the quality of lives of the patient population and their respective families and result in high economic burden. Accompanied by the high risk of significant disability, chronic pain also leads to psychological disorders such as depression and anxiety. More than 30% of chronic painaffected population reported difficulty in handling mundane tasks including cleaning, bathing, driving, sleeping, participating in fitness activities, and participating in social activities, among others.

Lower back pain is one of the most prevalent types of chronic pain and is the foremost cause of disability, globally. The global incidence of lower back pain was 576.9 million in 2017.The complexities involved in diagnosis and treatment are the leading contributors to the massive economic burden of lower back pain. More than 13% of incidence population, required surgery to overcome the severe pain.

Limited Efficacy of Opioids

Owing to the severity of pain and several detrimental effects of neurological disorders and chronic pain, the consumption of opiate drugs has witnessed significant growth in the past decade. According to CDC, total number of opioid prescriptions dispensed in 2012 were more than 255 million with a prescribing rate of 81.3 prescriptions per 100 persons in the U.S. The rising concerns regarding misuse and abuse of opioids have resulted in the emergence of stringent governmental regulations putting a control and restrictions on the prescription and sales of opioids.

High mortality rate pertaining to opioid use disorders, stringent government regulations, and high economic burden of pain management medication procedures, have significantly elevated the requirement for alternative pain management procedures with a reduced risk of mortality, increased efficacy of treatment resulting in enduring effect, and reduced risk of pain recurrence. The technological developments in interventional pain management procedures and breakthroughs in neural anatomy have resulted in the development of treatment technologies based on neural activity modulation. The specificity and potential of neuromodulation technologies to treat chronic pain and neurological disorders with minimal after-effects have resulted in massive adoption of neurostimulation devices.

BIS Research offers exclusive market intelligence reports on disruptive technologies. Each year we publish over 200 titles across industry verticals.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store